According to a media report on Sunday, one of the UK’s most senior medical chiefs has indicated that a vaccine against COVID-19 may be ready to be deployed by the start of the new year.
Jonathan Van-Tam, England’s deputy chief medical officer and one of the government’s advisors on the coronovirus epidemic, has reportedly told members of parliament (MPs) that the vaccine, made at the University of Oxford and produced by Astraseneca, would rollout soon after Christmas. Can be prepared for. In December.
In India, the vaccine has a serum Institute of India tie-up as it undergoes testing.
“The Sunday Times” quoted Van Tam as writing, “We are not far from it. It is not entirely unrealistic to suggest that we may deploy a vaccine immediately after Christmas. This has greatly reduced hospital admissions and deaths.” Will affect. Tell MPs during a briefing last week.
An MP who attended another briefing with Van-Tam told the newspaper that the drug was “very sharp about the third-phase AstraZeneca results they expect between the end of this month and the end of next”.
The MP said, “Van-Tam expects to protect the elderly and vulnerable. He has given us to understand that this will stop the outbreak of the virus. He said he would expect to be vaccinated in January.”
This comes as the UK government on Friday introduced new legislation that would allow a large number of health workers to administer the flu and a potential COVID-19 vaccine.
“COVID-19 vaccines are being developed rapidly, which will save people’s lives if they are successful,” Van-Tam quoted the new regulations.
“All vaccines must go through three stages of clinical trials and be evaluated by the regulator for safety and effectiveness before they are given to patients. The stated measures are intended to improve existing safeguards and protect existing patients who are safeguarded. The measures have to be strengthened. “
The Department of Health and Social Care (DHSC) said the new measures would increase access to vaccines against potentially killer diseases as well as support the government’s plans for the roll-out of a potential COVID-19 vaccine that is proven to be safe and effective. . Through strong clinical trials and approved for use by the regulator.
Britain’s Health Secretary Matt Bangkok said, “Every year millions of people in the National Health Service (NHS) have extensive experience of disease prevention.”
He said, “These legal changes will help us do everything that we can to ensure that we are ready to produce a safe and effective COVID-19 vaccine, as soon as it comes to clinical trials and regulatory Has undergone rigorous investigation, ”he said.
It aims to increase the number of fully trained and experienced health professionals to administer COVID-19 and flu vaccines under the NHS and local authority occupational health plans, as well as to enable an expanded workforce that Administer vaccinations to the public. The DHSC said this would make it easier and quicker for patients and health workers to access the vaccines needed to prevent fatal diseases.
Therefore, if a vaccine is developed before 2021, changes to human medicine regulations will affect existing powers that require the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) to authorize temporary supplies for any treatment or vaccine Which enables one to respond to public health. need.
This means that if a vaccine has been found to meet safety, quality and effectiveness standards by the MHRA, the vaccination can begin without waiting for the European Medicines Agency – which ends the transition period on 31 December this year Till then. – There would be only one body capable of granting licenses.
The Interim Chief Scientific Officer at MHRA, Drs. Christian Schneider said: “No vaccine will be deployed until rigorous standards are met through a comprehensive clinical trial program.”
“The preferred route to enable the deployment of any new vaccine remains through normal product licensing procedures. But reinforced security measures are now necessary for our ability to strengthen regulatory governance and protect public health, temporary authority. Must be required. “
Vaccines are first given to the elderly and vulnerable, followed by vaccinations to those at highest risk. Any population-wide roll-out is expected to be a very long-term process.
(This story has not been edited by NDTV employees and is auto-generated from a syndicated feed.)